Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a biopharmaceutical company developing and manufacturing innovative monoclonal antibodies for the treatment of cancer and serious viral infections.
Upcoming conferences
Abstract Presenter and Faculty Information
Abstract Submission Key Dates:
mid-October 2009: Annual Meeting abstract submission website opens
January 12, 2010 (11:59 PM EST): Abstract submission deadline
mid-March 2010: Abstract notifications are sent to first authors
March 29, 2010: Late-breaking abstract deadline
If you have any questions please contact Annual Meeting staff:
Abstract Submission Information: abstracts@asco.org or (571) 483-1400 (571) 483-1400, option 2.
Annual Meeting Faculty: speakers@asco.org or (571) 483-1400 (571) 483-1400, option 1.
SEC Exception
ASCO Sponsored and Co-Sponsored Meetings
Guidance for SEC Exception to Data Confidentiality
asco.org
Antibody Biology & Engineering
From Basic Mechanisms To Antibody-Based Therapeutics
March 7-12, 2010
Ventura Beach Marriott
Ventura, CA
• Therapeutic Antibodies
(Andrew Chan / Philip Thorpe / Wayne Marasco / Steve Jacobsen)
grc.org
A new national initiative involving where volunteers can be matched to a scientific research project, or clinical trial, for which they might qualify.
Interested adult volunteers, parents or caregivers register on the ResearchMatch Web site (www.researchmatch.org) and indicate their interest in participating in research studies. Both healthy volunteers and those with specific medical conditions can sign up.
Message 26090452
CRISP has a new site for checking on grants.
projectreporter.nih.gov |
